![Naseem Zojwalla](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Naseem Zojwalla
Chief Tech/Sci/R&D Officer at
OLEMA PHARMACEUTICALS, INC.
Net worth: 59 197 $ as of 30/05/2026
Profile
Naseem Zojwalla currently works at Olema Pharmaceuticals, Inc., as Chief Medical Officer from 2022.
Dr. Zojwalla also formerly worked at Peloton Therapeutics, Inc., as Vice President-Clinical Development from 2015 to 2020, Turning Point Therapeutics, Inc., as Vice President-Clinical Development from 2020 to 2022, and Columbia University Irving Medical Center, as Assistant Clinical Professor-Medicine.
Dr. Zojwalla received her undergraduate degree from Stanford University and doctorate degree from Temple University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/02/2026 | 4,488 ( 0.01% ) | 59 197 $ | 30/05/2026 |
Naseem Zojwalla active positions
| Companies | Position | Start |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 30/01/2022 |
Former positions of Naseem Zojwalla
| Companies | Position | End |
|---|---|---|
| TURG POIN | Chief Tech/Sci/R&D Officer | 31/12/2021 |
| PELOTON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2019 |
Columbia University Medical Center
 Columbia University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Naseem Zojwalla
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University Medical Center
Columbia University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University School of Medicine
 Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
- Stock Market
- Insiders
- Naseem Zojwalla
